Author/Authors :
Adam P. Fitzpatrick، نويسنده , , Hratch D. Kourouyan، نويسنده , , Andreana Siu، نويسنده , , Randall J. Lee، نويسنده , , Michael D. Lesh، نويسنده , , Laurence M. Epstein، نويسنده , , Jerry C. Griffin MD FACC، نويسنده , , Melvin M. Scheinman*، نويسنده ,
Abstract :
One hundred seven patients underwent atrioventricular (AV)-junctional ablation and pacing for atrial fibrillation, and 90 were alive 2.3 ± 1.2 years later. Quality of life index (1.9 ± 1.2 to 3.6 ± 1.1; 3.6 ± 1.1; p < 0.001) and ease of activities of daily living (2 ± 0.4 to 2.4 ± 0.3; p < 0.001) were significantly improved. Doctor visits (10 ± 13 to 5.06 ± 7; p < 0.03), hospital admissions (2.8 ± 6.8 vs 0.17 ± 0.54; p < 0.03), and antiarrhythmic drug trials (6.2 ± 4 to 0.46 ± 1.5; p < 0.001) decreased significantly after treatment. Congestive heart failure episodes decreased from 18 before to 8 afterward. Twenty-eight of 36 patients with dual-chamber pacemakers remained in a dual-chamber mode at follow-up. Radiofrequency AV-junctional catheter ablation and pacing is a highly successful form of treatment for medically refractory atrial fibrillation.